AI Breakthroughs Transform Drug Discovery, Cancer Detection, and Lab Automation
NVIDIA's $1B Eli Lilly partnership and BioNeMo platform adoption accelerate AI-driven drug discovery, while quantum computing and efficient AI reshape enterprise innovation on January 12, 2026.
By
Newsroom
